Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection

Journal of Viral Hepatitis

Volumn 15, Issue 6, 2008, Pages 434-441

  Papatheodoridis, G V ^a   Chrysanthos, N ^a   Hadziyannis, E ^a   Cholongitas, E ^a   Manesis, E K ^a  

^a KAT HOSPITAL   (Greece)

Author keywords

Alanine aminotransferase; HBV DNA; Hepatitis B; Inactive carriers; Predictors

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; VIREMIA; VIRUS CARRIER;

ADULT; ALANINE TRANSAMINASE; CARRIER STATE; CLINICAL ENZYME TESTS; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 43549105665     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00957.x     Document Type: Article

References (31)

1. Hadziyannis SJ. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Vir Hep Rev 1995 1 : 7 36.
2. Hadziyannis SJ, Papatheodoridis GV. Hepatitis Be antigen negative chronic hepatitis B - natural history and treatment. Semin Liver Dis 2006 26 : 130 141.
3. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-Summary of a workshop. Gastroenterology 2001 120 : 1828 1853.
4. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology 2004 39 : 857 861.
5. Papatheodoridis GV, Hadziyannis SJ. Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 2001 8 : 311 321.
6. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 : 507 539.
7. Manesis E, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003 98 : 2261 2267.
8. Keeffe EB, Dieterich DT, Han S-HB et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006 4 : 936 962.
9. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001 80 : 63 71.
10. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 699.
11. Brunetto MR, Giarin M, Oliveri F et al. Wild type and e antigen-minus hepatitis B virus in course of chronic hepatitis. Proc Natl Acad Sci USA 1991 88 : 4186 4190.
12. Brunetto MR, Oliveri F, Coco B et al. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long-term cohort study. J Hepatol 2002 36 : 263 270.
13. Kaneko M, Miller RH, Di Bisceglie AM, Feinstone SM, Hoofnagle JH, Purcell RH. Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. Gastroenterology 1990 99 : 799 804.
14. Jardi R, Buti M, Rodriguez-Frias F et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996 24 : 680 685.
15. Gerken G, Gomez J, Lambertico P et al. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 1998 74 : 155 165.
16. Jurinke C, Zollner B, Feucht HH et al. Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera. Genet Anal 1998 14 : 97 102.
17. Rasmussen R. Quantification on the lightcycler. In : Meyer S, Wittwer C, Nakagawara K, eds. Rapid Cycle Real Time PCR-Methods and Applications. New York : Springer, 2001 : 21 34.
18. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2001 34 : 1225 1241.
19. EASL International consensus conference on hepatitis B. J Hepatol 2003 39 (Suppl. 1 S3 S25.
20. Martinot-Peignoux M, Boyer N, Colombat M et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002 36 : 543 548.
21. Chu C-J, Hussain M, Lok ASF. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002 36 : 1408 1415.
22. Gish RG, Locarnini SA. Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol 2006 4 : 666 676.
23. Keeffe EB, Dieterich DT, Han SH et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004 2 : 87 106.
24. Papatheodoridis GV, Manesis EK, Manolakopoulos S et al. Is there a meaningful serum HBV DNA cut-off level for therapeutic decisions in HBeAg-negative chronic hepatitis B (CHBe-)? Hepatology 2006 44 (Suppl. 1 541.
25. de Franchis R, Meucci G, Vecchi M et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993 118 : 191 194.
26. Villeneuve J-P, Descrochers M, Infante-Rivard C et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994 106 : 1000 1005.
27. Hsu YS, Chien RN, Yeh CT et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002 35 : 1522 1527.
28. Manno M, Camma C, Schepis F et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004 127 : 756 763.
29. Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984 86 : 230 235.
30. Prati D, Taioli E, Zanella A et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002 137 : 1 10.
31. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. Br Med J 2004 328 : 983 989.